Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
BENCH-PRESS : Original Article
BEYOND CLINICAL ONCOLOGY : Original Article
Brainteaser
BREAST CANCER : Original Article
BREAST CANCERS Original Article
Brief Commentary MEDic LAWgic Section
Brief Report, Public Health
CANCER EPIDEMIOLOGY: Original Article
CANCER SURGERY : Original Article
Cardio-Oncology
Case Report
Case Series, Haematological
CLINICAL TRIAL : Original Article
COLORECTAL CANCER : Original Article
COMMENTARY
Consensus
Consensus Recommendations, Head Neck
Controversy
Corrigendum
Diagnostic Dilemma
Drug Review
DRUG REVIEW : Review Article
Editorial
Editorial Commentary
Editorial: Memoir
Erratum
ESOPHAGEAL CANCER : Original Article
FEMALE REPRODUCTIVE TRACT TUMORS : Original Article
GCT Review Article
GENITOURINARY : Original Article
GI CANCER Original Article
HEAD AND NECK CANCER : Original Article
HEAD AND NECK CANCER : Review Article
HEAD AND NECK CANCERS : Original Article
HISTOPATHOLOGY IN ONCOLOGY : Original Article
In Response
Letter to Editor
Letter to Editor, Breast
Letter to Editor: Oral Carcinoma
Letter to the Editor
Letters to Editor
Letters to the Editor
LEUKEMIA : Original Article
LEUKEMIAS : Original Article
LUNG CANCER: Original Article
METRONOMIC THERAPY IN AML : Original Article
METRONOMIC THERAPY IN HEAD AND NECK CANCERS : Original Article
METRONOMIC THERAPY IN LUNG CANCER : Original Article
METRONOMIC THERAPY IN OVARIAN CANCER : Original Article
Mini Commentary
Mini Symposium - FNAC VERSUS CORE BIOPSY: Editorial
Mini Symposium - FNAC VERSUS CORE BIOPSY: Original Article
Mini Symposium - RT DOSIMETRY AND FRACTIONATION: Editorial
Mini Symposium - RT DOSIMETRY AND FRACTIONATION: Original Article
Mini Symposium on Changing Landscape: Brief Article
Mini Symposium on Changing Landscape: Editorial
Mini Symposium on Changing Landscape: Original Article
Mini Symposium on CML
Mini Symposium on Supportive Care: Original Article
MINI SYMPOSIUM: HEAD AND NECK CANCER : Editorial
MINI SYMPOSIUM: HEAD AND NECK CANCER : Original Article
MINI SYMPOSIUM: HEAD AND NECK CANCER : Review Article
MINI SYMPOSIUM: HEAD AND NECK ONCOLOGY: Original Article
MINI SYMPOSIUM: MOLECULAR ONCOLOGY: Original Article
MINI SYMPOSIUM: PEDIATRIC ONCOLOGY: Original Article
MISCELLANEOUS : Original Article
MOLECULAR ONCOLOGY : Original Article
MULTIPLE CANCERS Original Article
MYELODYSPLASTIC SYNDROME : Review Article
MYELOID LEUKEMIA : Original Article
NEURO ONCOLOGY : Review Article
NEURO-ONCOLOGY : Original Article
None
Notice of Retraction
OESOPHAGEAL CANCER : Original Article
Oncology Reflections
Original Article
Original Article : Bone & Soft Tissue Tumors
ORIGINAL ARTICLE : Bone and Soft Tissue Sarcomas
ORIGINAL ARTICLE : Breast Cancer
Original Article : Breast Cancers
Original Article : Gastro-intestinal & Hepatobiliary Cancers
Original Article : Genitourinary & Gynecological Cancers
ORIGINAL ARTICLE : GI Cancer
ORIGINAL ARTICLE : GI Oncology
ORIGINAL ARTICLE : Gynaecologic Oncology
Original Article : Head and Neck Cancers
ORIGINAL ARTICLE : Hematolymphoid
Original Article : Leukemia & Lymphoma
ORIGINAL ARTICLE : Leukemia and Lymphoma
ORIGINAL ARTICLE : Melanoma and Skin Cancer
Original Article : Pediatric and Adolescent Cancers
ORIGINAL ARTICLE : SAARC Selection
ORIGINAL ARTICLE : Supportive Care and Others
Original Article, Breast
Original Article, Gastrointestinal
Original Article, Gynaecological
Original Article, Head Neck
Original Article, Neurological
Original Article, Public Health
Original Article: Bladder Cancer
Original Article: Bone and Soft Tissue Cancers
Original Article: Bone and Soft Tissue Tumor
ORIGINAL ARTICLE: Bone and Soft Tissue Tumors
Original Article: Brain Tumor
ORIGINAL ARTICLE: Brain Tumors
Original Article: Cancer Epidemiology and Screening
Original Article: Cancer Epidemiology, Screening and diagnosis
ORIGINAL ARTICLE: Diagnostics in Oncology
ORIGINAL ARTICLE: Epidemiology of Cancer and Cancer Screening
ORIGINAL ARTICLE: Gastro-intestinal & Hepatobiliary Cancer
Original Article: Gastrointestinal Cancer
Original Article: Genito Urinary Cancer
ORIGINAL ARTICLE: Genitourinary & Gynaecological Cancer
Original Article: Genitourinary Cancer
ORIGINAL ARTICLE: Genitourinary Cancers
Original Article: Geriatric Oncology
ORIGINAL ARTICLE: GI Cancers
Original Article: GI Cancers and Hepatobilliary Malignancies
ORIGINAL ARTICLE: Gynaecologic Cancers
ORIGINAL ARTICLE: Gynaecological Cancer
ORIGINAL ARTICLE: Gynaecological Cancers
Original Article: Gynecological Cancer
ORIGINAL ARTICLE: Head and Neck Cancer
ORIGINAL ARTICLE: Hematolymphoid Malignancies
Original Article: Hematolymphoid Malignancy
Original Article: Hepatobiliary Cancer
ORIGINAL ARTICLE: Immuno - Oncology
Original Article: Leukemia -Lymphoma and Myeloma
ORIGINAL ARTICLE: Leukemia, Lymphoma & Plasma Cell Disorder
Original Article: Lung Cancer
ORIGINAL ARTICLE: Lung Cancers
ORIGINAL ARTICLE: Neuroendocrine Tumors
Original Article: Paediatric Cancer
ORIGINAL ARTICLE: Palliative Care
ORIGINAL ARTICLE: Pediatric Oncology
ORIGINAL ARTICLE: Sarcomas
ORIGINAL ARTICLE: Sarcomas and Skin Cancer
Original Article: Skin Cancer
Original Article: Supportive and Palliative Care
Original Article: Supportive and Palliative Care in Cancer
ORIGINAL ARTICLE: Supportive Care
Original Research Article
PEDIATRIC ONCOLOGY : Original Article
PEDIATRIC SECTION: Editorial
PEDIATRIC SECTION: Original Article
Pictorial CME, Haematological
Poetry in Oncology
Position Paper
QUEST FOR AN ANTIDOTE TO RADIATION TOXICITY : Editorial
QUEST FOR AN ANTIDOTE TO RADIATION TOXICITY : Original Article
RCC Practical Consensus Recommendations
Regional Article
Review Article
Review Article, Breast
Review Article, Haematological
Review Article, International
SARCOMA : Original Article
SARCOMA Review Article
SOFT TISSUE SARCOMA : Original Article
South Asia update
SOUTH ASIAN UPDATE : An update
SOUTH ASIAN UPDATE : Original Article
TABACCO, THE MENACE : Original Article
THE CUTTING EDGE OF RADIOTHERAPEUTICS : Editorial
THE CUTTING EDGE OF RADIOTHERAPEUTICS : Original Article
THE GREAT DEBATE: Against HPV vaccine in cervical cancer
THE GREAT DEBATE: AGAINST IMATINIB AS THE FIRST LINE TKI CHOICE FOR CML
THE GREAT DEBATE: Editorial-HPV vaccine in cervical cancer
THE GREAT DEBATE: For HPV vaccine in cervical cancer
THE GREAT DEBATE: FOR IMATINIB AS THE FIRST LINE TKI CHOICE FOR CML
THE GREY-HAIRED CANCER PATIENT: Editorial
THE GREY-HAIRED CANCER PATIENT: Original Article
THE SKILLFUL SCALPEL: Editorial
THE SKILLFUL SCALPEL: Original Article
THE WAR ON MICROBES: Editorial
THE WAR ON MICROBES: Original Article
THROUGH THE MICROSCOPE : Original Article
THROUGH THE MICROSCOPE: Editorial
TREATMENT TOXICITY : Original Article
TRENDS IN HORMONAL THERAPY IN PROSTATE CANCER: Review Article
URO-ONCOLOGY : Original Article
View Point
Viewpoint
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
BENCH-PRESS : Original Article
BEYOND CLINICAL ONCOLOGY : Original Article
Brainteaser
BREAST CANCER : Original Article
BREAST CANCERS Original Article
Brief Commentary MEDic LAWgic Section
Brief Report, Public Health
CANCER EPIDEMIOLOGY: Original Article
CANCER SURGERY : Original Article
Cardio-Oncology
Case Report
Case Series, Haematological
CLINICAL TRIAL : Original Article
COLORECTAL CANCER : Original Article
COMMENTARY
Consensus
Consensus Recommendations, Head Neck
Controversy
Corrigendum
Diagnostic Dilemma
Drug Review
DRUG REVIEW : Review Article
Editorial
Editorial Commentary
Editorial: Memoir
Erratum
ESOPHAGEAL CANCER : Original Article
FEMALE REPRODUCTIVE TRACT TUMORS : Original Article
GCT Review Article
GENITOURINARY : Original Article
GI CANCER Original Article
HEAD AND NECK CANCER : Original Article
HEAD AND NECK CANCER : Review Article
HEAD AND NECK CANCERS : Original Article
HISTOPATHOLOGY IN ONCOLOGY : Original Article
In Response
Letter to Editor
Letter to Editor, Breast
Letter to Editor: Oral Carcinoma
Letter to the Editor
Letters to Editor
Letters to the Editor
LEUKEMIA : Original Article
LEUKEMIAS : Original Article
LUNG CANCER: Original Article
METRONOMIC THERAPY IN AML : Original Article
METRONOMIC THERAPY IN HEAD AND NECK CANCERS : Original Article
METRONOMIC THERAPY IN LUNG CANCER : Original Article
METRONOMIC THERAPY IN OVARIAN CANCER : Original Article
Mini Commentary
Mini Symposium - FNAC VERSUS CORE BIOPSY: Editorial
Mini Symposium - FNAC VERSUS CORE BIOPSY: Original Article
Mini Symposium - RT DOSIMETRY AND FRACTIONATION: Editorial
Mini Symposium - RT DOSIMETRY AND FRACTIONATION: Original Article
Mini Symposium on Changing Landscape: Brief Article
Mini Symposium on Changing Landscape: Editorial
Mini Symposium on Changing Landscape: Original Article
Mini Symposium on CML
Mini Symposium on Supportive Care: Original Article
MINI SYMPOSIUM: HEAD AND NECK CANCER : Editorial
MINI SYMPOSIUM: HEAD AND NECK CANCER : Original Article
MINI SYMPOSIUM: HEAD AND NECK CANCER : Review Article
MINI SYMPOSIUM: HEAD AND NECK ONCOLOGY: Original Article
MINI SYMPOSIUM: MOLECULAR ONCOLOGY: Original Article
MINI SYMPOSIUM: PEDIATRIC ONCOLOGY: Original Article
MISCELLANEOUS : Original Article
MOLECULAR ONCOLOGY : Original Article
MULTIPLE CANCERS Original Article
MYELODYSPLASTIC SYNDROME : Review Article
MYELOID LEUKEMIA : Original Article
NEURO ONCOLOGY : Review Article
NEURO-ONCOLOGY : Original Article
None
Notice of Retraction
OESOPHAGEAL CANCER : Original Article
Oncology Reflections
Original Article
Original Article : Bone & Soft Tissue Tumors
ORIGINAL ARTICLE : Bone and Soft Tissue Sarcomas
ORIGINAL ARTICLE : Breast Cancer
Original Article : Breast Cancers
Original Article : Gastro-intestinal & Hepatobiliary Cancers
Original Article : Genitourinary & Gynecological Cancers
ORIGINAL ARTICLE : GI Cancer
ORIGINAL ARTICLE : GI Oncology
ORIGINAL ARTICLE : Gynaecologic Oncology
Original Article : Head and Neck Cancers
ORIGINAL ARTICLE : Hematolymphoid
Original Article : Leukemia & Lymphoma
ORIGINAL ARTICLE : Leukemia and Lymphoma
ORIGINAL ARTICLE : Melanoma and Skin Cancer
Original Article : Pediatric and Adolescent Cancers
ORIGINAL ARTICLE : SAARC Selection
ORIGINAL ARTICLE : Supportive Care and Others
Original Article, Breast
Original Article, Gastrointestinal
Original Article, Gynaecological
Original Article, Head Neck
Original Article, Neurological
Original Article, Public Health
Original Article: Bladder Cancer
Original Article: Bone and Soft Tissue Cancers
Original Article: Bone and Soft Tissue Tumor
ORIGINAL ARTICLE: Bone and Soft Tissue Tumors
Original Article: Brain Tumor
ORIGINAL ARTICLE: Brain Tumors
Original Article: Cancer Epidemiology and Screening
Original Article: Cancer Epidemiology, Screening and diagnosis
ORIGINAL ARTICLE: Diagnostics in Oncology
ORIGINAL ARTICLE: Epidemiology of Cancer and Cancer Screening
ORIGINAL ARTICLE: Gastro-intestinal & Hepatobiliary Cancer
Original Article: Gastrointestinal Cancer
Original Article: Genito Urinary Cancer
ORIGINAL ARTICLE: Genitourinary & Gynaecological Cancer
Original Article: Genitourinary Cancer
ORIGINAL ARTICLE: Genitourinary Cancers
Original Article: Geriatric Oncology
ORIGINAL ARTICLE: GI Cancers
Original Article: GI Cancers and Hepatobilliary Malignancies
ORIGINAL ARTICLE: Gynaecologic Cancers
ORIGINAL ARTICLE: Gynaecological Cancer
ORIGINAL ARTICLE: Gynaecological Cancers
Original Article: Gynecological Cancer
ORIGINAL ARTICLE: Head and Neck Cancer
ORIGINAL ARTICLE: Hematolymphoid Malignancies
Original Article: Hematolymphoid Malignancy
Original Article: Hepatobiliary Cancer
ORIGINAL ARTICLE: Immuno - Oncology
Original Article: Leukemia -Lymphoma and Myeloma
ORIGINAL ARTICLE: Leukemia, Lymphoma & Plasma Cell Disorder
Original Article: Lung Cancer
ORIGINAL ARTICLE: Lung Cancers
ORIGINAL ARTICLE: Neuroendocrine Tumors
Original Article: Paediatric Cancer
ORIGINAL ARTICLE: Palliative Care
ORIGINAL ARTICLE: Pediatric Oncology
ORIGINAL ARTICLE: Sarcomas
ORIGINAL ARTICLE: Sarcomas and Skin Cancer
Original Article: Skin Cancer
Original Article: Supportive and Palliative Care
Original Article: Supportive and Palliative Care in Cancer
ORIGINAL ARTICLE: Supportive Care
Original Research Article
PEDIATRIC ONCOLOGY : Original Article
PEDIATRIC SECTION: Editorial
PEDIATRIC SECTION: Original Article
Pictorial CME, Haematological
Poetry in Oncology
Position Paper
QUEST FOR AN ANTIDOTE TO RADIATION TOXICITY : Editorial
QUEST FOR AN ANTIDOTE TO RADIATION TOXICITY : Original Article
RCC Practical Consensus Recommendations
Regional Article
Review Article
Review Article, Breast
Review Article, Haematological
Review Article, International
SARCOMA : Original Article
SARCOMA Review Article
SOFT TISSUE SARCOMA : Original Article
South Asia update
SOUTH ASIAN UPDATE : An update
SOUTH ASIAN UPDATE : Original Article
TABACCO, THE MENACE : Original Article
THE CUTTING EDGE OF RADIOTHERAPEUTICS : Editorial
THE CUTTING EDGE OF RADIOTHERAPEUTICS : Original Article
THE GREAT DEBATE: Against HPV vaccine in cervical cancer
THE GREAT DEBATE: AGAINST IMATINIB AS THE FIRST LINE TKI CHOICE FOR CML
THE GREAT DEBATE: Editorial-HPV vaccine in cervical cancer
THE GREAT DEBATE: For HPV vaccine in cervical cancer
THE GREAT DEBATE: FOR IMATINIB AS THE FIRST LINE TKI CHOICE FOR CML
THE GREY-HAIRED CANCER PATIENT: Editorial
THE GREY-HAIRED CANCER PATIENT: Original Article
THE SKILLFUL SCALPEL: Editorial
THE SKILLFUL SCALPEL: Original Article
THE WAR ON MICROBES: Editorial
THE WAR ON MICROBES: Original Article
THROUGH THE MICROSCOPE : Original Article
THROUGH THE MICROSCOPE: Editorial
TREATMENT TOXICITY : Original Article
TRENDS IN HORMONAL THERAPY IN PROSTATE CANCER: Review Article
URO-ONCOLOGY : Original Article
View Point
Viewpoint
View/Download PDF

Translate this page into:

Original Article
13 (
04
); 315-319
doi:
10.1055/s-0044-1788050

Evaluation of Applicability of Tumor Budding and Poorly Differentiated Clusters as Additional Prognostic Markers in Colorectal Cancers

Department of Pathology, Employees State Insurance Post Graduate Institute of Medical Sciences and Research (ESI PGIMSR), Manicktala, Kolkata, West Bengal, India
Department of Pathology, Prafulla Chandra Sen Government Medical College and Hospital, Arambagh, West Bengal, India
Department of Pathology, Employees State Insurance Corporation (ESIC) Medical College, Bihta, Patna, Bihar, India
Author image
Corresponding author: Sudipta Chakrabarti, MD, Bihta, Patna 801103, Bihar, India. sudiptach@gmail.com
Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
Disclaimer:
This article was originally published by Thieme Medical and Scientific Publishers Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.

Abstract

Abstract

Purpose

Very few studies have assessed tumor budding (TB) and poorly differentiated cell clusters (PDCs) simultaneously in colorectal cancers (CRCs). The goal of this study was to establish a correlation between these two pertinent histological features and to reinforce the importance of their incorporation in routine histopathological reporting of CRC cases as a means to predict clinical outcome.

Methods

Resection specimens of colorectal carcinoma were included in the study. Patients who received presurgical therapy, or refused consent were excluded. PDC and TB were evaluated in routine hematoxylin and eosin-stained histopathological sections taken from the advancing edge of the tumor. TB and PDC were reported by selecting a “hotspot” chosen after review of all available slides with invasive tumor. It was then followed by their correlation with other known prognostic factors.

Results

Spearman's rho calculator for strength of association between TB and PDC as well as association of TB and PDC individually with known prognostic factors revealed statistical significance. Correlation of TB and PDC with histologic grade, primary tumor (pT), and regional lymph node (pN) stage was done based on one-way analysis of variance calculator, which yielded statistically significant results.

Conclusion

Evaluation of these two histological parameters in the same hotspot field at the tumor invasive front plays a fundamental role in the definition of cancer aggressiveness and prediction of tumor behavior.

Keywords

PubMed

Introduction

The tumor invasive front is a significant interface of tumor host interactions which regulates tumor progression. Tumor budding (TB) is a histological hallmark at the tumor invasive front which supposedly initiates invasion and eventually metastasis.1 According to the International Tumor Budding Consensus Conference (ITBCC) criteria, TB is defined as a single tumor cell or a cluster of fewer than five tumor cells detached from the main tumor at the invasive front, while clusters of five or more tumor cells lacking gland formation are termed as poorly differentiated clusters (PDCs).23

TB has been designated as an adverse prognostic factor in colorectal cancers (CRCs) by the International Union against Cancer (UICC). The UICC has included TB under “additional prognostic markers,” besides histologic grade, perineural invasion (PNI), and tumor border.456

Tumor grade based on glandular differentiation is an important predictive factor of CRC aggressiveness. However, this system poses a significant interobserver variability due to the absence of objectivity in assessment of glandular component. A novel histological grading system based on PDCs has been highlighted that is expected to achieve an objective assessment of tumor differentiation.7 Besides, PDC is strongly predictive of unfavorable histological features, namely, infiltrating tumor borders, TB, lymph vascular, and PNI in CRCs.8910

PDCs and tumor buds form a continuum of morphological features with a randomly set cut-point of 5 tumor cells to distinguish between the two.23 PDCs possibly represent the evolution of tumor buds, which acquire proliferative and aggregative potential. Thus, they have common molecular, clinical, and pathological features of CRC cases.3

Very few studies have assessed the development of TB and PDC simultaneously in CRCs. Evaluation of these two histological parameters in the same hotspot field at the tumor invasive front is expected to assume a fundamental role in the definition of cancer aggressiveness and prediction of tumor behavior.

PDC and TB can be evaluated in routine hematoxylin and eosin-stained histopathological sections taken from the advancing edge of the tumor.

The present study aims to evaluate TB and PDC simultaneously in CRC cases by morphological assessment. The study further strives to establish a correlation of these two parameters with other known prognostic factors of CRCs.

The goal of our study was to establish a correlation between these two pertinent histological features and to reinforce the importance of their incorporation in routine histopathological reporting of CRC cases as a means to predict clinical outcome.

Materials and Methods

The study was conducted in the department of pathology over a period of 1 year (May 2020 to May 2021). Resection specimens of colorectal carcinoma received in the department of pathology were included in the study. Patients who received presurgical therapy, or refused consent were excluded from the study. After applying the exclusion criteria, 54 cases were included in the study. The current study was a single institutional, noninterventional, observational, prospective study. Clinical parameters were analyzed followed by histomorphological assessment of colonic resection specimens. Pertinent macroscopic findings of each specimen were tabulated after diligent assessment. Formalin-fixed paraffin-embedded tissue blocks were cut at 4 µm thickness and stained with hematoxylin and eosin. Histopathological reporting was done according to the College of American Pathologists protocol for the Examination of Resection Specimens from Patients with Primary Carcinoma of the Colon and Rectum (Version: Colon and Rectum Resection 4.1.0.0; Protocol Posting Date: February 2020). TB was reported by selecting a “hotspot” chosen after review of all available slides with invasive tumor. The total number of buds were reported in an area measuring 0.785 sq.mm, which corresponded to 20× field in LM-52-6000 Mega, LYNX Penta Head Microscope (based on the ITBCC, 2016 recommendation).23 Both total number of buds and a three-tier score (based on 0.785 sq.mm field area) were reported: low (0–4 buds), intermediate (5–9 buds), and high (10 or more buds). PDC was evaluated in the advancing edge of the tumor in the same hotspot field as TB. The cases were categorized into three grades based on the highest PDC count: grade 1 (G1) count less than 5, grade 2 (G2) range between 5 and 9, and grade 3 (G3) 10 or more. TB and PDC data of each CRC case was assessed simultaneously. It was then followed by their correlation with other known prognostic factors, namely, tumor border, radial margin involvement, lymphovascular (LVI) and PNI, dirty tumor necrosis, histological grade, and pathological stage. All cases were initially assessed by a single pathologist blinded to other data followed by review of the cases by a second pathologist. Discordant findings, if any, were finally assessed by a third pathologist and the consensus opinion was incorporated in the final tabulation. Statistical analysis of the data was performed using the “social science statistics” Web site and the statistical tests employed were one-way analysis of variance (ANOVA) calculator, including Tukey's honest significant difference (HSD) and Spearman's rho calculator (https://www.socscistatistics.com/).

Results and Analysis

A total of 54 CRC cases were studied. The patients belonged to a wide age range spanning from 3rd to the 6th decades, majority being in the range of 50 to 54 years (20.4%). Fifty-six percent patients were females. Sixty-one percent of the cases presented with involvement of the left colon. Rectum was the most common tumor location. Bulk of the cases (57.4%) was of histologic grade 2. Note that 81.5% of the cases belonged to pT3. Resection margins were uninvolved in 70.4% of the cases (Table 1).

Table 1
Distribution of cases based on demographic/pathologic characteristics and TNM staging

Sex

 Female

30 (55.6%)

 Male

24 (44.4%)

Tumor location

 Caecum

12 (22.2%)

 Ascending colon

04 (7.4%)

 Hepatic flexure

04 (7.4%)

 Splenic flexure

02 (3.7%)

 Descending colon

02 (3.7%)

 Sigmoid colon

03 (5.6%)

 Rectosigmoid

02 (3.7%)

 Rectum

15 (27.8%)

 Anal canal

01 (1.8%)

 Caecum and IC junction

02 (3.7%)

 Rectum and anal canal

05 (9.3%)

 Left colic flexure and part of descending colon

02 (3.7%)

Histologic grade

 G1

19 (35.2%)

 G2

31 (57.4%)

 G3

04 (7.4%)

Primary tumor (pT)

 pT1

01 (1.8%)

 pT2

03 (5.6%)

 pT3

44 (81.5%)

 pT4

10 (18.5%)

Regional lymph nodes (pN)

 pN0

23 (42.6%)

 pN1

15 (27.8%)

 pN2

16 (29.6%)

TNM stage

 Stage I

4 (7.4%)

 Stage II

40 (74.1%)

 Stage III

10 (18.5%)

Abbreviation: IC, ileocecal.

TB score was done according to the ITBCC guidelines and the study comprised 37% low TB score, and 31.5% each of intermediate and high scores. PDC was evaluated and graded in the advancing edge of the tumor in the same hotspot field as TB. Low, intermediate, and high PDC scores were noted in 9.3, 66.6, and 24.1% cases, respectively, in the present study (Fig. 1).

Morphology of tumor budding (TB) and poorly differentiated cluster (PDC) scores in different histologic grade of tumor (hematoxylin and eosin [H&E], 200×). (A) TB score: Low (04) and PDC: G2 (05). (B) TB score: Intermediate (06) and PDC: G3 (10). (C) TB score: High (13) and PDC: G3 (10). (D) TB score: High (10) and PDC: G2 (08).
Fig. 1: Morphology of tumor budding (TB) and poorly differentiated cluster (PDC) scores in different histologic grade of tumor (hematoxylin and eosin [H&E], 200×). (A) TB score: Low (04) and PDC: G2 (05). (B) TB score: Intermediate (06) and PDC: G3 (10). (C) TB score: High (13) and PDC: G3 (10). (D) TB score: High (10) and PDC: G2 (08).

Spearman's rho calculator for strength of association between TB and PDC as well as association of TB and PDC individually with known prognostic factors, namely, lymph node metastasis, LVI, and PNI, revealed statistical significance. The correlation of TB with LVI and PNI was found to be statistically significant (p = 0.008 for TB vs. LVI, p = 0.005 for TB vs. PNI); however, the correlation of PDC with LVI and PNI was not statistically significant. Correlation of TB and PDC with histologic grade, primary tumor (pT), and regional lymph node (pN) stage was done based on one-way ANOVA calculator, including Tukey's HSD, which yielded statistically significant results (Table 2). Also, the correlation of TB and PDC individually with overall TNM stage was statistically significant. TB was found to be better correlated to TNM stage compared to PDC (p = 0.004 for TB vs. TNM, p = 0.008 for PDC vs. TNM). Hence, the present study establishes the prognostic significance of TB and PDC as well as their relation with known prognostic factors in CRCs, thereby reinforcing the importance of their incorporation in routine reporting. Furthermore, these two parameters when used in conjunction provide objectivity in grading the CRC cases and strengthens the histologic grading system for better risk stratification.

Table 2
Correlation of TB and PDC with histologic grade, primary tumor (pT), and regional lymph node (pN) stage (based on one-way ANOVA calculator, including Tukey's HSD)

TB: PDC

M1 = 7.19

M2 = 7.35

0.17

Q = 0.38 (p = 0.96152)

TB: G

M1 = 7.19

M3 = 1.72

5.46

Q = 12.37 (p = 0.00000)

PDC: G

M2 = 7.35

M3 = 1.72

5.63

Q = 12.74 (p = 0.00000)

The f-ratio value is 52.58697. The p-value is < 0.00001.

(M1: mean of TB, M2: mean of PDC, M3: mean of histologic grade)

TB: pN

M1 = 7.19

M3 = 0.85

6.33

Q = 14.26 (p = 0.00000)

PDC: pN

M2 = 7.35

M3 = 0.85

6.50

Q = 14.64 (p = 0.00000)

The f-ratio value is 69.62738. The p-value is < 0.00001.

(M1: mean of TB, M2: mean of PDC, M3: mean of pN stage)

TB: pT stage

M1 = 7.19

M3 = 3.07

4.11

Q = 9.32 (p = 0.00000)

PDC: pT stage

M2 = 7.35

M3 = 3.07

4.28

Q = 9.69 (p = 0.00000)

The f-ratio value is 30.14761. The p-value is < 0.00001.

(M1: mean of TB, M2: mean of PDC, M3: mean of pT stage)

Abbreviations: ANOVA, analysis of variance; G, histologic grade; HSD, honest significant difference; PDC, poorly differentiated cell clusters; pN, regional lymph nodes; pT, primary tumor; TB, tumor budding.

Note: The result is significant at p < 0.05. A blue value for Q (below) indicates a significant result.

Discussion

TB is one of the preliminary steps of cancer progression, as TB cells invade extracellular matrix and lymphovascular spaces, thereby giving rise to metastatic deposits in lymph nodes and distant organs. PDCs were first defined in 2008 and are a predictive and prognostic factor in CRCs. Tumor grading by TB and PDC scoring has been used with a view to achieving greater objectivity compared to histologic grading alone.11121314 Our present study was conducted to reinforce the prognostic value of TB when used simultaneously with PDC in CRCs.

According Lugli et al and Marx et al, in CRC, pTB (peritumoral TB) and iTB (intratumoral TB) are important indicators of higher TNM stage and tumor grade, LVI, or nodal and distant metastases.1516 Resemblances in adverse prognostic roles of pTB and iTB were established in a study by Lugli et al.16 The present study also revealed that the TB positively correlated with histologic grade and pTNM stage (p-value is < 0.00001).

In a study by Zlobec et al, it was found that iTB could also identify the patients who might show aggressive behavior and benefit from adjuvant therapy in a subgroup of node-negative CRC.17 Hence, routine reporting of TB will help in identifying a subgroup of patients who will require adjuvant therapy.

Ueno et al in their study delineated that pPDC (peritumoral PDC) was a more accurate prognostic indicator than pTB.311

Archilla et al, in their study delineated the fact that lymph nodal tumor burden significantly correlates with newer prognostic indicators, namely, higher TB and PDC scores in CRCs.18 The current study has revealed similar findings.

As per the study by Mohan et al, statistically significant association was found between TB and LVI (p < 0.01) as well as TB vs. PNI (p = 0.002). The current study also showed similar statistically significant results.19

Study on PDC in colorectal carcinoma by Maurya et al failed to show any significant association between PDC and depth of invasion (pT) with p-value of 0.136.20 While the study by Shah et al revealed significant correlation between TB with T stage, N stage, and TNM stage.21 This was in concordance with the present study in which the correlation between PDC and pT was found to be statistically significant with a p-value of < 0.05.

The current study reinforced the fact that the correlation of TB and PDC individually with overall TNM stage was statistically significant. However, TB was found to be better correlated to TNM stage compared to PDC (p = 0.004 for TB vs. TNM, p = 0.008 for PDC vs. TNM).

TB and PDC are associated with the epithelial-mesenchymal transition phenomena, which is triggered by the Wnt/beta-catenin signaling pathway.22223 Transition of TB to a mesenchymal phenotype is mediated by nuclear translocation of beta-catenin and simultaneous loss of membranous E-cadherin expression. The development of PDC is associated with the upregulation of L1 cell adhesion molecule (L1CAM), which mediates epithelial cell migration and is one of the target factors of the Wnt signaling pathway.2223

The present study strives to establish the importance of simultaneous assessment of TB and PDC in the prognostication of CRCs since both the parameters have significant positive correlation with histologic grade and pTNM stage. However, one weakness of the study is that the survival data of the study population could not be incorporated.

Conclusion

The study reinforces the fact that even in a resource poor setup, morphological assessment of TB and PDC will help achieve a greater objectivity in prognostication of CRCs than histologic grade alone. Identification of cases with higher TB score will in turn help to select subgroups who have a more aggressive behavior and likely to benefit from adjuvant chemotherapy. This current study also emphasizes the importance of scoring PDC in the same hotspot field that is used in the assessment of TB to strengthen the prognostic and predictive significance of TB in CRCs.

References

  1. , , . Tumour budding in colorectal cancer: molecular rationale for clinical translation. Nat Rev Cancer. 2018;18(04):203-204.
    [Google Scholar]
  2. , , , et al . Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016. Mod Pathol. 2017;30(09):1299-1311.
    [Google Scholar]
  3. , , , et al . New criteria for histologic grading of colorectal cancer. Am J Surg Pathol. 2012;36(02):193-201.
    [Google Scholar]
  4. , , , , , . Prognostic value of tumor “budding” in patients with colorectal cancer. Dis Colon Rectum. 1993;36(07):627-635.
    [Google Scholar]
  5. , , , , . Tumor budding in colorectal carcinoma: time to take notice. Mod Pathol. 2012;25(10):1315-1325.
    [Google Scholar]
  6. , , . Prognostic and predictive factors in colorectal cancer. Postgrad Med J. 2008;84(994):403-11.
    [Google Scholar]
  7. , , , et al . APC mutation and tumour budding in colorectal cancer. J Clin Pathol. 2003;56(01):69-73.
    [Google Scholar]
  8. , , , . Budding is useful to select high-risk patients in stage II well-differentiated or moderately differentiated colon adenocarcinoma. Dis Colon Rectum. 2003;46(10):1400-1406.
    [Google Scholar]
  9. , , , , , , . A new prognostic staging system for rectal cancer. Ann Surg. 2004;240(05):832-839.
    [Google Scholar]
  10. , , , , , . Characterization of the immunological microenvironment of tumour buds and its impact on prognosis in mismatch repair-proficient and -deficient colorectal cancers. Histopathology. 2011;59(03):482-495.
    [Google Scholar]
  11. , , , et al . Site-specific tumor grading system in colorectal cancer: multicenter pathologic review of the value of quantifying poorly differentiated clusters. Am J Surg Pathol. 2014;38(02):197-204.
    [Google Scholar]
  12. , , , , , , . Histologic grading based on counting poorly differentiated clusters in preoperative biopsy predicts nodal involvement and pTNM stage in colorectal cancer patients. Hum Pathol. 2014;45(02):268-275.
    [Google Scholar]
  13. , , , et al . Poorly differentiated clusters (PDCs) as a novel histological predictor of nodal metastases in pT1 colorectal cancer. Virchows Arch. 2014;464(06):655-662.
    [Google Scholar]
  14. , , , , , , . Colorectal carcinoma grading by quantifying poorly differentiated cell clusters is more reproducible and provides more robust prognostic information than conventional grading. Virchows Arch. 2012;461(06):621-628.
    [Google Scholar]
  15. , , , et al . High-grade intratumoral tumor budding is a predictor for lymphovascular invasion and adverse outcome in stage II colorectal cancer. Int J Colorectal Dis. 2020;35(02):259-268.
    [Google Scholar]
  16. , , , et al . Intratumoral budding as a potential parameter of tumor progression in mismatch repair-proficient and mismatch repair-deficient colorectal cancer patients. Hum Pathol. 2011;42(12):1833-1840.
    [Google Scholar]
  17. , , , et al . Intratumoural budding (ITB) in preoperative biopsies predicts the presence of lymph node and distant metastases in colon and rectal cancer patients. Br J Cancer. 2014;110(04):1008-1013.
    [Google Scholar]
  18. , , , et al . Lymph node tumor burden correlates with tumor budding and poorly differentiated clusters: a new prognostic factor in colorectal carcinoma? Clin Transl Gastroenterol. 2021;12(03):e00303.
    [Google Scholar]
  19. , , , . Assessment of tumour budding in colorectal carcinoma and its correlation with pathological staging among patients undergoing resection at a tertiary care hospital in Kerala, India. J Clin Diagn Res. 2023;17(10):EC01-EC07.
    [Google Scholar]
  20. , , , . A study of significance of poorly differentiated clusters in colorectal carcinomas: association with histopathological prognostic factors. J Clin Diagn Res. 2020;14(11):EC28-EC32.
    [Google Scholar]
  21. , , , , , . Tumor budding as a prognostic indicator in colorectal carcinoma: a retrospective study of primary colorectal carcinoma cases in a tertiary care center. Indian J Surg Oncol. 2022;13(03):459-467.
    [Google Scholar]
  22. , , , et al . New insights into the role of EMT in tumor immune escape. Mol Oncol. 2017;11(07):824-846.
    [Google Scholar]
  23. , , , et al . Epithelial-mesenchymal transition (EMT) signature is inversely associated with T-cell infiltration in non-small cell lung cancer (NSCLC) Sci Rep. 2018;8(01):2918.
    [Google Scholar]
Show Sections